Our data clearly demonstrate that Nutlin-3 treatment completely inhibited the invasiveness of melanoma cells through an impaired IGF-1-mediated matrix metalloproteinases type 2 activation mechanism (92). The gene discussed is IGF1; the disease is melanoma.